Penelope Lowe Prize
Title is to be short and informative, containing major keywords, in 12 points Times New Roman, upper case, bold and justified.
To be formatted with the author's family name and then first initial with the presenting author in bold. Superscript numbers must be used to indicate the author's institution.
Smith B1, Pattermore M2 and Ward L2
1University of Sydney, Sydney, NSW 2University of Queensland, St Lucia, QLD
Detail the city, state and country (in this order) of the organisations/institutions and appropriate superscript numbers. Don't include degrees or professional titles, for example Dr or Prof.
Must be in 10 point Times New Roman, single-spaced and justified. Abstracts are to be a maximum of 500 words, including references.
Abstract should address:
Include 1 to 2 sentences to introduce the broad topic area, the context of the case and explains its relevance and importance.
- Case Description/Method
In this section information on participants (and/or subjects) should be provided. Data may include demographic information such as age and gender as well as describe in sequence the history, physical examination, investigative studies, and the patient's progress.
The purpose of the results section is to provide a description of the main findings and outcomes. Submitted abstracts must include actual results; reference to inferred results that were unavailable at the time of submission is not acceptable, however, data from additional analyses after abstract submission is allowed. This should include relevant literature review.
In this section you should provide statements of interpretation and implication findings, as well as comparison with previous literature. It should include nominated questions.
A minimum of 2 and maximum of 5 key references are to be included.
Use standard abbreviations only within the body of the abstract. When using abbreviations spell out the name in full at the first mention and follow with the abbreviation in parenthesis. Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract. Capitalise the first letter of trade names.
Care should be taken to ensure high quality English expression and grammar.
Abstract submission terms and conditions
By submitting an abstract, you are confirming each author listed in the abstract:
- agrees with the content of the abstract and has given permission to be listed as an author/presenter
- has checked the accuracy of the information and referencing within the abstract
- has been granted all appropriate consents and approvals from any third party for the use of information provided
- has complied with all legislation, including that relating to the privacy of any person or patient
- allows RACP to publish the abstract in College documents and on the College and Congress website royalty-free, with non-exclusive perpetual licence to use, reproduce and publish all materials associated and any subsequent submission, presentation or slides associated with the abstract and, to modify and adapt them (but only to the extent that it is necessary for such use and publication)
- allows RACP to live stream and/or record any associated presentation and make a recording of it available on the College or Congress website
- consents that RACP may publish the personal details of the authors including their email address, as listed in the abstract
- allows RACP to publish all photographs taken which relate to it
- will assist in media activity including interviews, as reasonably requested by RACP
- agrees to the terms and conditions tick box as final step in the submission process